Swixx BioPharma Revenue and Competitors
Estimated Revenue & Valuation
- Swixx BioPharma's estimated annual revenue is currently $155.6M per year.
- Swixx BioPharma's estimated revenue per employee is $201,000
Employee Data
- Swixx BioPharma has 774 Employees.
- Swixx BioPharma grew their employee count by 7% last year.
Swixx BioPharma's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Co-Founder | Reveal Email/Phone |
2 | Director Tax, Treasury and Finance Projects | Reveal Email/Phone |
3 | Finance Director CZ | Reveal Email/Phone |
4 | Medical Director Poland | Reveal Email/Phone |
5 | Chief Compliance Officer | Reveal Email/Phone |
6 | Pharmacovigilance Manager | Reveal Email/Phone |
7 | Regulatory & Pharmacovigilance Manager | Reveal Email/Phone |
8 | Regulatory, Pharmacovigilance and Quality Manager | Reveal Email/Phone |
9 | Compliance Manager CZ&SK | Reveal Email/Phone |
10 | Quality and Regulatory Manager | Reveal Email/Phone |
Swixx BioPharma Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $10.5M | 52 | 2% | N/A | N/A |
#2 | $155.6M | 774 | 7% | N/A | N/A |
#3 | $40.8M | 203 | 10% | N/A | N/A |
#4 | $245.6M | 1222 | -24% | N/A | N/A |
#5 | $142.3M | 708 | 0% | N/A | N/A |
#6 | $141.1M | 702 | -9% | N/A | N/A |
#7 | $16.7M | 83 | 28% | N/A | N/A |
#8 | $16.5M | 82 | 8% | N/A | N/A |
#9 | $21.3M | 106 | 15% | N/A | N/A |
#10 | $13.7M | 68 | -1% | N/A | N/A |
What Is Swixx BioPharma?
Swixx BioPharma is designed to fully replace biopharma, OTC and medical device multinationals' subsidiaries or business units in those countries, or therapeutic areas of CEE, that the multinational chooses not to enter, or to exit
keywords:N/A
N/A
Total Funding
774
Number of Employees
$155.6M
Revenue (est)
7%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Swixx BioPharma News
2022-03-22 - No small feat': Albireo CEO talks biotech's commercial ...
In other territories, it has hired third-party marketers such as Jadiete (Japan), Medison Pharma (Israel) and Swixx Biopharma (Central and Eastern Europe).